MARKET WIRE NEWS

Summers Value Partners Q4 2024 Partner Letter

Source: SeekingAlpha

2025-01-30 08:30:00 ET

Summary

  • In 2024, the Summers Value Fund LP delivered a net return of 27.4%, outperforming its benchmarks, the Russell 2000 Index ETF and the Russell 2000 Value Index ETF.
  • The Fund's strategy focuses on business quality, positive change factors, and long-term investment orientation, benefiting from both long and short positions.
  • Key contributors included Electromed and UFP Technologies, while detractors were Zimvie, Utah Medical, and Premier Inc.
  • We remain committed to treating our limited partners fairly, aligning our interests, and offering unique investment opportunities through single-purpose vehicles or deal funds.

Dear Fellow Partners:

In 2024, the Summers Value Fund LP ("the Fund") delivered a net 1 return of 27.4%. The Fund outperformed its primary benchmark, the Russell 2000 Index ETF ( IWM ), which returned 11.3% for the year. The Fund also outperformed its secondary benchmark, the Russell 2000 Value Index ETF ( IWN ), which returned 7.7% for the year. Since inception, the Fund has achieved an annualized net 1 return of 12.8%, compared to the Russell 2000 Index ETF's annualized return of 6.0% and the Russell 2000 Value Index ETF's annualized return of 5.4%. Our strategy has benefited from our focus on business quality and positive change factors, combined with our long-term investment orientation....

Read the full article on Seeking Alpha

For further details see:

Summers Value Partners Q4 2024 Partner Letter
ModivCare Inc Com

NASDAQ: MODV

MODV Trading

-24.0% G/L:

$0.4411 Last:

16,101,135 Volume:

$0.5305 Open:

mwn-ir Ad 300

MODV Latest News

MODV Stock Data

$6,220,052
10,556,374
0.04%
8
N/A
Healthcare Providers & Services
Healthcare
US
Denver

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App